Memorial Sloan Kettering Cancer Center – Head of the Division of Pediatric Solid Tumors and Chief of the Pediatric Sarcoma Service

Dr. Reed is a pediatric hematologist-oncologist on the MSK Kids team at Memorial Sloan Kettering Cancer Center. He specializes in the care of children, adolescents, and young adults with sarcomas and other solid tumors with expertise in studying the changes that happen in tumors to make them resistant to therapies. His research is focused on characterizing the mechanisms of therapeutic resistance and drives the development of therapies with better capacities to overcome resistance and reduce disease relapse. Dr. Reed founded the Sunshine Project, the Pediatric Cancer Foundation’s pediatric Phase 1 clinical trial consortium. This collaborative venture unites the nation’s top doctors and researchers to find a faster cure for pediatric cancer. He also holds leadership roles in multiple collaborative groups, including Vice Chair of the Bone Tumor Committee for the Children’s Oncology Group and Vice President of the Connective Tissue Oncology Society. In 2024, he will assume the position of President for the latter organization.

Dr. Reed earned his MD from Case Western Reserve University School of Medicine in Cleveland, OH. He completed a combined pediatric residency program at Boston Children’s Hospital-Harvard Medical School and Boston Medical Center-Boston University School of Medicine. This training was followed by a fellowship in pediatric hematology/oncology at St. Jude Children’s Research Hospital.